6505--36C261-21-AP-3004 | 640-22-1-053-0008 Y-90 Theraspheres .

Closed Solicitation Posted

Not the latest version. See the latest pre-solicitation from .

Solicitation number
36C26121Q0608
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

Notice text

TheraSphere s Y-90 microspheres therapy is a minimally invasive outpatient procedure and patients usually go home hours after the procedure is completed. As of March 2021, TheraSphere Y-90 is the only recently fully FDA approved microsphere radiation therapy in the United States for the treatment of colorectal cancer that has spread to the liver. Theraspheres is a radiotherapy treatment for hepatocellular carcinoma (HCC) that consists of millions of microscopic, radioactive glass microspheres being infused into the arteries that feed liver tumors. These microspheres then embolize, lodging themselves in the liver's capillaries and bathing the malignancy in high levels of yttrium-90 radiation.

Files

File Type Posted
36C26121Q0608.docx DOCX document

Notice history

Notice Type Posted
6505--36C261-21-AP-3004 | 640-22-1-053-0008 Y-90 Theraspheres. Produce "C" PO Latest pre-solicitation Pre-Solicitation
This notice Solicitation
6505--36C261-21-AP-3004 | 640-22-1-053-0008 Y-90 Theraspheres . Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors